Dr. Lucia Viola on IASLC Nomination, Expanding Screening Access, and AI in Lung Cancer Care
What does it take to elevate thoracic oncology across an entire region?
Meet Dr. Lucia Viola, interventional pulmonologist and head of thoracic oncology service at Fundación Neumológica Colombiana, as she shares her powerful journey from a small Colombian town to becoming a nominee for the IASLC Board of Directors. In this in-depth interview with Emma Ter-Azaryan, Content Coordinator of OncoDaily TV, Dr. Viola discusses how she built one of Colombia’s most comprehensive lung cancer programs, the systemic challenges in Latin America, and her vision for a more equitable, AI-enhanced future in cancer care.
Key Highlights:
- Nomination to the IASLC Board of Directors 2025
- The power and limits of AI in early lung cancer detection
- Mentorship, imagination, and purpose as keys to leadership
- Her message to young oncologists worldwide
00:00 Introduction
01:04 Dr. Lucia Viola’s current roles and affiliations
03:14 Founding the lung cancer screening program
05:03 Joining IASLC and finding a global research community
08:52 Challenges of thoracic oncology in Latin America
10:25 IASLC election process and eligibility
14:50 Barriers to quality cancer care in low-resource regions
22:38 The potential of AI in lung cancer diagnosis
35:06 Advice for young researchers: mentorship, curiosity, and empathy
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023